المؤلفون: Machiko Abe, Elamin H. Elbasha, Palmer Cody, Keisuke Tobe

المصدر: BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Infectious Diseases

مصطلحات موضوعية: Male, Pediatrics, Intraepithelial neoplasia, Epidemiology, Cost effectiveness, Cost-Benefit Analysis, Uterine Cervical Neoplasms, Alphapapillomavirus, Genital warts, 0302 clinical medicine, Japan, Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18, And oropharyngeal cancer, Vulvar, 030212 general & internal medicine, Child, Aged, 80 and over, Cervical cancer, Vaccines, education.field_of_study, Cost effectiveness analysis, Incidence, Incidence (epidemiology), Vaccination, Cost-effectiveness analysis, Middle Aged, Vaginal, Anal, Infectious Diseases, Recurrent respiratory papillomatoses, Child, Preschool, 030220 oncology & carcinogenesis, Female, Cervical, Public Health, Quality-Adjusted Life Years, Research Article, Adult, medicine.medical_specialty, Human papillomavirus, Adolescent, Population, Herd protection/immunity, lcsh:Infectious and parasitic diseases, Disease transmission models, Young Adult, 03 medical and health sciences, medicine, Humans, lcsh:RC109-216, education, Aged, Immunization Programs, business.industry, Public health, Papillomavirus Infections, Condylomata acuminate, Infant, Models, Theoretical, medicine.disease, Oral cavity, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad477bd1893e3c418a6112907cf49dec
https://doaj.org/article/03f9ca13ca8044fe8774c5d801a5fdd0

المؤلفون: Praveen Dhankhar, Camilo J. Acosta, Chizoba Nwankwo, Elamin H. Elbasha, Michelle G. Goveia, Andreas Lauschke, M. Pillsbury

المصدر: Value in Health. 18:358-367

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Cost effectiveness, Cost-Benefit Analysis, Hepatitis A vaccine, Young Adult, hepatitis A virus, Environmental health, Humans, Medicine, Child, Aged, Aged, 80 and over, Hepatitis A Vaccines, Transmission (medicine), business.industry, Health Policy, Public health, Infant, Newborn, cost-effectiveness analysis, Public Health, Environmental and Occupational Health, Infant, Hepatitis A, Cost-effectiveness analysis, Middle Aged, simulation, medicine.disease, United States, Vaccination, Models, Economic, Vaccination policy, Child, Preschool, Immunology, herd protection/immunity, Female, Public Health, hepatitis A vaccine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::911cd22b3409998495caca992f866945
https://doi.org/10.1016/j.jval.2015.02.004